The EU Innovation Network, in conjunction with ACT EU is organising an information and training webinar on Simultaneous National Scientific Advice (SNSA) on 19 April 2024.
Full agenda and registration here!
About the Scientific Advice:
The provision of scientific advice for medicines and medical devices .For medicines, the European Medicines Agency advises on the appropriate tests and studies required in the development or quality of a medicine. For medical devices, the expert panels created by the European Commission advise on clinical studies required in the development of high-risk medical devices.
The objectives of the webinar are to:
- provide information on the ongoing SNSA pilot, including the rationale behind this initiative and experience to date;
- outline the circumstances in which SNSA could be used, including some case studies;
- summarise the optimised procedure for phase 2 of the SNSA pilot;
- highlight the benefits for applicants;
- answer questions and invite feedback from stakeholders in relation to SNSA.
This EMA-hosted webinar anticipates a broad representation of stakeholders who may benefit from using SNSA including pharmaceutical companies, SMEs, and non-commercial or academic researchers and developers, funding bodies, etc.
Ask your questions:
Participants are encouraged to use Slido to submit questions in advance of the webinar. The most popular questions will be answered by speakers during the Q & A session.
Access slido and check:
- Event name: SNSA Information and Training Webinar
- Access code: #SNSAwebinarApril
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.